SENNA LAXATIVE- sennosides 8.6 mg tablet

Senna Laxative by

Drug Labeling and Warnings

Senna Laxative by is a Otc medication manufactured, distributed, or labeled by NUVICARE LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredient

Sennosides 8.6 mg

Purpose

Laxative

Uses:

• relieves occasional constipation (irregularity).
• generally produces a bowel movement in 6 to 12 hours

Warnings:

Do not use

• Laxative products for longer than 1 week, unless directed by a doctor.

ASK DOCTOR

Ask a doctor before use if you have

• Stomach pain 
• nausea
• vomiting, 
• Noticed a sudden change in bowel habits that continues over a period of 2 weeks.

STOP USE

Stop use and ask a doctor if you have:

• Rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

PREGNANCY OR BREAST FEEDING

If pregnant or breast-feeding, ask a health professional before use.

KEEP OUT OF REACH OF CHILDREN

KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. 

DIRECTIONS

• Take preferably at bedtime or as directed by a doctor.

age	starting dosage	maximum dosage
adults & children 12 years of age and over	2 tablets once a day	4 tablets twice a day
children 6 to under 12 years	1 tablet once a day	2 tablets twice a day
children 2 to under 6 years	1 /2 tablet once a day	1 tablet twice a day
children under 2 years	ask a doctor	ask a doctor

OTHER INFORMATION

• store at 20-25°C (68-77°F) excursions permitted between15°-30°C (59°-86°F)
• each tablet contains: Calcium 25 mg & sodium 3 mg

INACTIVE INGREDIENTS

Colloidal silicon dioxide,croscarmellose sodium, Dicalcium phosphate, Hypromellose, liquid paraffin, magnesium stearate, microcrystalline cellulose, Maltodextrin, Purified water, Sodium lauryl sulphate, Stearic Acid.

QUESTIONS OR COMMENTS?

Call 1 (718) 337-8733 or visit: support@nuvicare.com

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

SENNA LAXATIVE 
sennosides 8.6 mg tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 84324-012
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	8.6 mg

Inactive Ingredients
Ingredient Name	Strength
SODIUM LAURYL SULFATE (UNII: 368GB5141J)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
STEARIC ACID D7 (UNII: T3B081197X)
PARAFFIN (UNII: I9O0E3H2ZE)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
HYPROMELLOSES (UNII: 3NXW29V3WO)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MALTODEXTRIN (UNII: 7CVR7L4A2D)
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)

Product Characteristics
Color	brown	Score	no score
Shape	ROUND	Size	10mm
Flavor		Imprint Code	S8
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 84324-012-01	200 in 1 BOTTLE; Type 0: Not a Combination Product	07/17/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	505G(a)(3)	07/17/2024

Labeler - NUVICARE LLC (119257565)

Registrant - NUVICARE LLC (119257565)